Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.22 USD | -0.19% | -1.13% | -18.76% |
Apr. 16 | Foghorn Therapeutics Names Kristian Humer CFO | MT |
Apr. 16 | Foghorn Therapeutics Inc. Appoints Kristian Humer as Chief Financial Officer | CI |
Business Summary
Number of employees: 116
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medicines
100.0
%
| 19 | 100.0 % | 34 | 100.0 % | +77.63% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 19 | 100.0 % | 34 | 100.0 % | +77.63% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 17-04-30 | |
Douglas Cole
FOU | Founder | 63 | 15-09-30 |
Fanny Cavalié
COO | Chief Operating Officer | 46 | - |
Steven Bellon
CTO | Chief Tech/Sci/R&D Officer | 59 | 16-05-31 |
Chief Tech/Sci/R&D Officer | 53 | 23-09-10 | |
Andrew Germain
LAW | General Counsel | - | 19-12-31 |
Saurabh Sewak
PRN | Corporate Officer/Principal | - | 21-12-31 |
Carlos Costa
HRO | Human Resources Officer | 51 | - |
Michael LaCascia
LAW | General Counsel | 59 | 20-11-11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Simba Gill
BRD | Director/Board Member | 60 | 17-06-30 |
Douglas Cole
FOU | Founder | 63 | 15-09-30 |
B. Parshall
BRD | Director/Board Member | 69 | 22-08-15 |
Ian Smith
BRD | Director/Board Member | 58 | 21-04-26 |
Adam Koppel
BRD | Director/Board Member | 54 | 17-06-30 |
Thomas Lynch
BRD | Director/Board Member | 63 | 22-10-26 |
Director/Board Member | 69 | 17-03-31 | |
Scott Biller
BRD | Director/Board Member | 68 | 20-01-08 |
Chief Executive Officer | 49 | 17-04-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 42,565,904 | 32,012,092 ( 75.21 %) | 0 | 75.21 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.76% | 223M | |
-2.32% | 103B | |
+0.40% | 95.71B | |
+2.39% | 22.02B | |
-16.75% | 20.9B | |
-9.07% | 17.85B | |
-42.83% | 16.21B | |
-15.16% | 15.52B | |
+3.64% | 13.86B | |
+34.69% | 12.04B |
- Stock Market
- Equities
- FHTX Stock
- Company Foghorn Therapeutics Inc.